Neuropsychologists and psychiatrists argue the evidence for broad-scale implementation of psychedelic drug use is insufficient
Get our morning and afternoon news emails, free app or daily news podcast
The decision by Australia’s drugs regulator to allow authorised psychiatrists to prescribe psychedelic drugs is “questionable, if not concerning”, and likely driven by the influence of lobby groups instead of health experts, mental health researchers say.
As of 1 July, authorised psychiatrists have been able to prescribe medicines containing psilocybin for treatment-resistant depression, and MDMA for post-traumatic stress disorder. The decision by the Therapeutic Goods Administration followed public consultation, a report from an expert panel and advice received from a medicines advisory committee.
About Author
More Stories
More than 330,000 buildings without power as ex-Tropical Cyclone Alfred brings dangerous rain and winds
Keir Starmer’s poll ratings leap after Trump withdraws support for Ukraine
German election winner Merz moves step closer to forming government